Please assess the completion status of the following clinical trial:

Trial Title: Role of Children in Transmission of COVID-19 to Immunocompromised Patients

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Immunocompromised patient followed at UCLA Health~* Immunocompromised patient \>1 day old to \<60 years of age~* Patient with a diagnosis of breast, lung, or colorectal cancers, lymphoma, acute/chronic leukemia, multiple myeloma, or other solid tumors and are receiving chemotherapy~* Patients who have received a hematopoietic stem cell transplantation within the last year~* Patients who have received a solid organ transplantation within the last year~Exclusion Criteria:~* Immunocompromised patients with positive SARS-CoV-2 test prior to study enrollment

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Families with Children (Type: None): Families containing an immunocompromised individual that have children in the family setting.
- Famlies without children (Type: None): Families containing an immunocompromised individual that do not have children in the family setting.

Based on this trial design, predict the completion outcome and termination type (if applicable).